A New US-UK Diagnostic Project: Mood Elevation and Depression in First-year Undergraduates at Oxford and Stanford Universities
Overview
Authors
Affiliations
Objective: To investigate differences in prevalence of mood elevation, distress and depression among first-year undergraduates at Oxford and Stanford universities.
Method: An online survey was sent to Oxford and Stanford first-year undergraduate students for two consecutive years in the winter of 2005 and 2006. Students completed a survey that assessed mood symptoms and medication use.
Results: Both universities had similar rates of distress by General Health Questionnaire (Oxford - 42.4%; Stanford - 38.3%), depression by Primary Care Evaluation of Mental Disorders (Oxford - 6.2%; Stanford - 6.6%), and psychotropic and non-psychotropic medication usage (psychotropic: Oxford - 1.5%; Stanford 3.5%; nonpsychotropic: Oxford - 13.3%; Stanford - 18%). Oxford had higher rates of mood elevation by Mood Disorder Questionnaire (MDQ) (Oxford - 4%; Stanford - 1.7%).
Conclusion: Oxford and Stanford students have similar rates of mood distress, depression and general medication usage. Students at Oxford have a higher prevalence of MDQ scores that possibly indicate a bipolar disorder, while Stanford students are prescribed more psychotropics.
Insomnia Medication Use by University Students: A Systematic Review.
Wang M, Cooper R, Green D Pharmacy (Basel). 2023; 11(6).
PMID: 37987381 PMC: 10661327. DOI: 10.3390/pharmacy11060171.
Why sleep matters for young people who may get depressed.
Goodwin G Interface Focus. 2020; 10(3):20190115.
PMID: 32382407 PMC: 7202387. DOI: 10.1098/rsfs.2019.0115.
Subjective responses to amphetamine in young adults with previous mood elevation experiences.
Schepers S, Arndt D, Rogers R, Hedeker D, de Wit H Psychopharmacology (Berl). 2019; 236(11):3363-3370.
PMID: 31209507 PMC: 7053220. DOI: 10.1007/s00213-019-05295-z.
Sheaves B, Porcheret K, Tsanas A, Espie C, Foster R, Freeman D Sleep. 2015; 39(1):173-81.
PMID: 26350467 PMC: 4678337. DOI: 10.5665/sleep.5342.
Yip S, Doherty J, Wakeley J, Saunders K, Tzagarakis C, de Wit H Neuropsychopharmacology. 2012; 37(8):1808-15.
PMID: 22491350 PMC: 3376329. DOI: 10.1038/npp.2012.45.